Frontlight ResearchEarly access
Colorectal cancer trials in Thailand
2 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
- Where
- Bangkok, Chiang Mai, Songkhla
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06750094 · EU 2024-513853-66-00 - Phase 3Taking peopleStudy of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Where
- Bangkok
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Amgen
See details and how to joinNCT06252649